SixOne Solutions
Bad entry?
First in class targeted therapy for metastatic breast cancer
We are developing first in class products for treating metastatic breast cancer. Our products address a novel target, Eya/Six1 not targeted by current cancer drugs. The central role of Eya/Six1 in breast cancer, and, importantly, in metastasis, was discovered ...